✦ LIBER ✦

Long-term therapy for rheumatoid arthritis

✍ Scribed by JuanJ. Gómez-Reino

Book ID: 118561010
Publisher: The Lancet
Year: 1996
Tongue: English
Weight: 383 KB
Volume: 347
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(96)90531-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The safety and efficacy of the use of me

The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis

✍ Joel M. Kremer; Joong Kil Lee 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 999 KB

Tuberculosis cutis colliquativa during l

Tuberculosis cutis colliquativa during long-term immunosuppressive therapy for rheumatoid arthritis

✍ G.-C. Sutor; J. Ockenga; P. Kirschner; C. Schätzle; M. Mendila; M. Jendro; M. St 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 314 KB

Long-term methotrexate (MTX) combination

Long-term methotrexate (MTX) combination therapy versus MTX alone for active rheumatoid arthritis

✍ Hanyu, Tadamasa ;Arai, Katsumitsu ;Ishikawa, Hajime 📂 Article 📅 1999 🏛 Informa UK (Informa Healthcare) 🌐 English ⚖ 804 KB

Safety of long-term tacrolimus therapy f

Safety of long-term tacrolimus therapy for rheumatoid arthritis: an open-label, uncontrolled study in non-elderly patients

✍ Shinichi Kawai; Kortaro Tanaka; Iwao Ohno; Kazunori Utsunomiya; Yoshihiko Seino 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 361 KB

Risk factors for the development of gast

Risk factors for the development of gastric mucosal lesions in rheumatoid arthritis patients receiving long-term nonsteroidal anti-inflammatory drug therapy and the efficacy of famotidine obtained from the FORCE study

✍ Yasunori Kobata; Hiroshi Yajima; Junichi Yamao; Yasuhito Tanaka; Hiroshi Fukui; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 311 KB

Long-term cyclophosphamide therapy in rh

Long-term cyclophosphamide therapy in rheumatoid arthritis

✍ William M. Fosdick; James L. Parsons; Donald F. Hill 📂 Article 📅 1968 🏛 John Wiley and Sons 🌐 English ⚖ 594 KB

YTOTOXIC AGENTS have been used for C more than a decade in therapy of rheumatoid However, therapy with these agents has not been widely adopted. It has been restricted, in general, to short intensive courses for acutely ill, hospitalized patients as utilized in cancer chemotherapy. We have used Cyc